ERBITUX Trademark Information

Trademark by IMCLONE LLC

pharmaceutical preparation, namely, monoclonal antibody for the treatment of cancer

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: 2/19/2004
First Use In Commerce: 2/19/2004
General Information
Word mark: ERBITUX
Status/Status Date:
REGISTERED AND RENEWED
6/28/2014
Serial Number: 76018914
Filing Date: 4/4/2000
Registration Number: 2865372
Registration Date: 7/20/2004
Goods and Services: pharmaceutical preparation, namely, monoclonal antibody for the treatment of cancer
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 3/6/2001
Last Applicant/Owner:
IMCLONE LLC
New York, NY 10016
Mark Drawing Code: Typeset (Words/letter/Number)
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
Eli Lilly and Company
Lilly Corporate Center
Indianapolis IN 46285
Current Status:
REGISTERED AND RENEWED
6/28/2014
Correspondent Search:
Robert E. Lee, Jr. is a correspondent of ERBITUX trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on